Form 4: Health Catalyst COO Sells Shares Under 10b5-1 Trading Plan

Daniel LeSueur, COO of Health Catalyst, Inc., sold 5,209 shares of common stock at $4.1475 per share on April 3, 2025, under a pre-arranged trading plan.

Summary

• On April 3, 2025, Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), sold 5,209 shares of the company's common stock.
• The sale was executed at a price of $4.1475 per share.
• This transaction was conducted under a pre-arranged trading plan established on March 7, 2024, in accordance with Rule 10b5-1.
• Following the transaction, LeSueur directly owns 211,041 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This is a routine disclosure of an insider stock sale. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on the company is likely minimal unless there are other similar sales.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Health Catalyst, HCAT, Daniel LeSueur, Chief Operating Officer, stock sale, Form 4, Rule 10b5-1, insider trading